Piloting the IPROACTIF Program to Preserve Functioning and Prevent Cognitive Decline
- Conditions
- Heart Disease (Coronary Artery Disease, Ischemic Heart Disease, Hypertensive Heart Disease)Uncontrolled Diabetes (HBA1c ≥ 10)
- Interventions
- Other: IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning)Other: Usual primary care services
- Registration Number
- NCT04682977
- Lead Sponsor
- University of Illinois at Chicago
- Brief Summary
Conduct a pilot randomized control to assess the preliminary efficacy of IPROACTIF, an occupational therapist-delivered primary care intervention for aging and chronic disease management.
- Detailed Description
The IPROACTIF intervention is based on the premise of preventing the physical and cognitive decline that is associated with aging and chronic disease. The 12-week intervention includes a comprehensive assessment of ADL functioning and ten intervention sessions addressing disease management, physical activity and executive functioning. This pilot randomized control trial will compare whether patients who receive IPROACTIF perform better than usual care patients on physical functioning, self-efficacy for chronic disease management, physical activity levels, executive functioning, health-related quality of life, and participation in life roles and activities.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 45
- English speaking
- Community-dwelling
- 55 years of age
- Primary diagnosis of heart disease (coronary artery disease, ischemic heart disease, hypertensive heart disease), or uncontrolled diabetes (HBA1c greater than/equal to 10)
- Self-reported risk of functional decline (score of 3 or higher) on the 11-item Brief Risk Identification of Geriatric Health Tool or self-reported need for assistance with disease management
Exclusion Criteria
- Current/past diagnosis of stroke or other neurological disorders
- Receiving pharmacological treatment for cognition
- Participating in other exercise or ADL-focused intervention studies
- Non-English speaking
- Residing in a long-term care institution
- Compromised decision-making capacity (score >8 on SOMCT)
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description IPROACTIF IPROACTIF (Integrated PRimary Care and Occupational Therapy for Aging and Chronic Disease Treatment to preserve Independence and Functioning) 10 weekly sessions. First two sessions focus on comprehensive assessment of physical and executive functioning, assessment of home safety and accessibility, assessment of ADL/IADL competence and performance in context; information in these areas is used by the interventionist to collaboratively identify three patient-centered goals. Goal planning is followed by 10 treatment sessions. Treatment sessions focus on chronic disease education, problem solving issues related to disease management by modifying daily routines, recommendations for embedding physical activity in everyday tasks, and environmental modifications or activity adaptations to increase ADL/IADL independence. Usual care Usual primary care services Participants in the control group will receive usual services which might include primary care and prescription medications for chronic disease management.
- Primary Outcome Measures
Name Time Method Physical functioning measured using the PROMIS Physical Function Short Form 20 12 weeks Self-reported assessment with raw scores ranging from 20 to 100; higher scores indicate better physical functioning
Performance of daily living tasks using the Performance Assessment of Self-care Skills 12 weeks Performance-based measure; summary score for each task ranges from 0-12; higher scores indicate better performance
Physical functioning measured using the Patient-Specific Functional Scale 12 weeks Self-reported assessment; scoring depends on number of activities rated, for a single activity, scores can range from 0 to 10; higher scores indicate better physical functioning
Physical functioning measured using the Physical Performance Test (9-item) 12 weeks Performance-based assessment; scores can range from 0 to 36; higher scores indicate better physical functioning
Executive functioning using the Dimensional Change Card Sort Test 12 weeks Performance-based measure; scores range from 0-10; higher scores indicate better performance
Executive functioning using the Executive Function Performance Test 12 weeks Performance-based measure; only the medication management task will be used; scores range from 0-25 for this task; higher scores indicate poorer performance
- Secondary Outcome Measures
Name Time Method Physical activity level 12 weeks Total minutes per day in moderate to vigorous physical activity and sedentary activity as measured by an accelerometer worn for at least 12 hours over seven consecutive days.
Self-efficacy for chronic disease management using the Chronic Disease Self-Efficacy and Self-Management Measures 12 weeks Self-reported assessment; range of possible scores varies by subscale; generally higher scores indicate better self-efficacy and self-management
Health related quality of life using the PROMIS Global Health Measure (physical and mental subscales) 12 weeks Self-reported assessment; raw scores for both sub-scales range from 4-20; higher score indicated better health-related quality of life
Participation in life activities and roles using the Late Life Functioning and Disability Index 12 weeks Self-rated measure; scaled scores for both dimensions (frequency and limitation) range from 0-100; higher scores indicate less difficulty i.e. better performance
Trial Locations
- Locations (1)
University of Illinois at Chicago
🇺🇸Chicago, Illinois, United States